ZAR1
Zygote arrest protein 1
Also known as: Z3CXXC6, ZAR1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86SH2
- Gene
- ZAR1
- Ensembl
- ENSG00000182223
- Chromosome
- 4
- Canonical length
- 424 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This maternal effect gene is oocyte-specific and encodes a protein that is thought to function in the initiation of embryogenesis. A similar protein in mouse is required for female fertility. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
424 residues, UniProt reviewed canonical sequence.
>Q86SH2|ZAR1
1 MAALGDEVLD GYVFPACPPC SYRYPYPAAT KGKGAAGGSW QQRGRGCLPA SSPCSAGAAS
61 LSFPGCGRLT AAEYFDSYQR ERLMALLAQV GPGLGPRARR AGSCDVAVQV SPRIDAAVQC
121 SLGRRTLQRR ARDPESPAGP GAEGTTGGGS FSQQPSRRGL EQGSPQNGAP RPMRFPRTVA
181 VYSPLALRRL TAFLEGPGPA AGEQRSGASD GERGPPPARL QGPEEGEVWT KKAPRRPQSD
241 DDGEAQAAVR ASWEQPADGP ELPPREAQEG EAAPRSALRS PGQPPSAGRA RDGGDGREAA
301 VAGEGPSPRS PELGKERLRF QFLEQKYGYY HCKDCNIRWE SAYVWCVQGT NKVYFKQFCR
361 TCQKSYNPYR VEDITCQSCK QTRCSCPVKL RHVDPKRPHR QDLCGRCKGK RLSCDSTFSF
421 KYIILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZAR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 1.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 1.3 nTPM
- ovary: 0.9 nTPM
- midbrain: 0.6 nTPM
- bone marrow: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- salivary gland: 0.2 nTPM
Single-cell type
- oocytes: 115 nCPM
- late spermatids: 11 nCPM
- early spermatids: 5 nCPM
- thyrotrophs: 5 nCPM
- other brain neurons: 2.3 nCPM
- undifferentiated spermatogonia: 1.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 7 nTPM
- cerebral cortex: 3.3 nTPM
- hypothalamus: 2.9 nTPM
- basal ganglia: 1.6 nTPM
- white matter: 1.3 nTPM
- pons: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- membraneless organelle assembly
- mRNA stabilization
- negative regulation of translation
- oocyte maturation
- translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ZAR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZAR1 as an antibody target. Whether an autoantibody or antibody against ZAR1 could matter depends on whether native ZAR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZAR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZAR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...